Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 7112345...102030...Last »

Sanofi files U.S. antitrust lawsuit against Mylan

Sanofi SA sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment.

Read More »

Theranos Accused of Running Fake Tests

A lawsuit brought against beleaguered blood-testing company Theranos alleges the company committed fraud by faking its blood-testing demonstrations.

Read More »

Becton Dickinson to acquire Bard for $24 billion

U.S. medical equipment supplier Becton Dickinson and Co. will acquire C. R. Bard Inc. in a $24 billion cash-and-stock deal, adding Bard’s devices to its portfolio in the high-growth sectors of oncology and surgery, both companies said.

Read More »

GSK must pay $3 million in generic Paxil suicide lawsuit: U.S. jury

GlaxoSmithKline must pay $3 million to a woman who sued the drug company over the death of her husband, a lawyer who committed suicide after taking a generic version of the antidepressant Paxil, a U.S. jury said.

Read More »

Up to 4,100 Children Victims of Epilepsy Drug

French health officials said a drug manufactured by Sanofi caused between 2,150 and 4,100 major fetal malformations between the years 1967 and 2016.

Read More »

Verily launches study to track health data

Verily is launching a four-year study with about 10,000 participants to understand how people transition from being healthy to becoming sick.

Read More »

Allergan, Argentum settle patent dispute over eye drug Restasis

U.S. generic drug company Argentum Pharmaceuticals LLC said it reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan’s eye drug Restasis.

Read More »

J&J first-quarter 2017 revenue misses estimates

Johnson & Johnson reported disappointing pharmaceutical and consumer product sales for first-quarter 2017 as revenue missed analyst estimates.

Read More »

Theranos Could Have Lab Again in 2019

Theranos reached a settlement with the Centers for Medicare and Medicaid Services, which could make it eligible to operate a clinical lab within two years.

Read More »

Abbott, Alere End Merger Legal Battle

Abbott Laboratories and Alere Inc. have come to an accord. Illinois-based Abbott will acquire Alere for an amount less than the initially agreed upon $5.8 billion.

Read More »

Bristol-Myers licenses two drugs to Biogen, Roche

Bristol-Myers Squibb Co. said it would license two of its drugs to Biogen Inc. and Roche Holding AG for an upfront fee of $470 million.

Read More »

University of California files CRISPR patents appeal

The University of California is appealing a U.S. patent ruling over the game-changing gene editing technology known as CRISPR that favored the Broad Institute, a research affiliate of Harvard University and the Massachusetts Institute of Technology.

Read More »

Maryland lawmakers approve bill to fight drug price gouging

Maryland lawmakers have passed a first-in-the-nation measure that lets the state attorney general sue generic drug makers that sharply raise prices in a move aimed at fighting “price gouging.”

Read More »

SEC Cracks Down on “Fake Biotech News”

The Securities and Exchange Commission singled out four biotech companies for allegedly promoting “fake news” in an attempt to manipulate share prices.

Read More »

UK cost agency turns down Bristol drug

Britain’s healthcare cost-effectiveness watchdog NICE said Bristol-Myers Squibb’s immunotherapy drug Opdivo was not worth using on the state health service for treating head and neck cancer due to its high price.

Read More »

Stada Accepts $5.6 Billion Takeover Offer

After weeks of bidding and speculation, German-based Stada Arzneimittel AG accepted a $5.6 billion takeover bid from Bain Capital and Cinven Partners LLP.

Read More »

Mallinckrodt resigns membership from PhRMA

Scrutinized and controversial drugmaker Mallinckrodt, a company at the center of a drug pricing scandal, resigned its membership from the Pharmaceutical Research and Manufacturers Association (PhRMA) ahead of changes to membership bylaws, per reports.

Read More »

GSK recalling nearly 600,000 asthma inhalers in U.S.

GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect that may cause them to deliver fewer doses of the medicine than indicated, the British drugmaker said.

Read More »

Massive $1.2 Billion Biotech Center in New York Will Create Thousands of New Jobs

A proposed $1.2 billion biotech development is projected to bring up to 12,000 jobs to the greater NYC area.

Read More »

Mallinckrodt agrees to U.S. drug probe settlement

Mallinckrodt Plc agreed to pay $35 million to resolve U.S. probes into its monitoring and reporting of suspicious orders of controlled substances.

Read More »

Page 1 of 7112345...102030...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2017 Focus: Top 10 Pipelines, Agenda 2017 and more!


Ad Right Bottom

Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.

Main Navigation